Latest News About Novo Nordisk A/S - Site Bagsværd (Nn1)

Updated 2026-05-06 13:06

I don’t have real-time access to the latest news right now. Here’s how you can quickly find the latest news about Novo Nordisk A/S at Bagsværd (NN1):

If you’d like, I can monitor a few reputable sources and summarize any Bagsværd-related updates you’re most interested in (e.g., new facilities, investments, regulatory approvals) as soon as I can access current data. Also, tell me whether you want a brief bulletin-style summary or a deeper dive with context on potential impacts on production, employment, and regional economics.

Sources

Novo Nordisk A/S

establishing a new production site. The new site will feature a state-of-the-art finished production facility and warehouse spanning over 40,000 m2. Designed to be modular and flexible, it will accommodate multiple product types within rare disease, such as haemophilia, both now and in the future.

via.ritzau.dk

Novo Nordisk A/S

Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark. News … Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more than 16 billion Danish kroner (€2.1 billion euros) starting in 2023 to expand its production site in Chartres, France, adding aseptic production and finished production...

chemanager-online.com

Novo Nordisk A/S | Globenewswire

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

via.ritzau.dk

Novo Nordisk A/S | Globenewswire - Via Ritzau

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

via.ritzau.dk

More Topics